Request for Covid-19 Impact Assessment of this Report
The United States Vancomycin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vancomycin market, reaching US$ million by the year 2028. As for the Europe Vancomycin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vancomycin players cover Pfizer, Eli Lilly and Company, CJ CheilJedang, and Xellia Pharmaceuticals ApS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vancomycin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Daptomycin
Linezolid
Quinupristin
Ampicillin
Chloramphenicol
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Eli Lilly and Company
CJ CheilJedang
Xellia Pharmaceuticals ApS
VIANEX
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix.
MicuRx Pharmaceuticals
Nabriva Therapeutics
NovaBay Pharmaceuticals
NovoBiotic Pharmaceuticals
Oragenics
Sealife Pharma
Taiwan Zhengde Pharmaceutical
Zhejiang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
North China Pharmaceutical
Shenwei Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vancomycin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vancomycin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vancomycin by Country/Region, 2017, 2022 & 2028
2.2 Vancomycin Segment by Type
2.2.1 Daptomycin
2.2.2 Linezolid
2.2.3 Quinupristin
2.2.4 Ampicillin
2.2.5 Chloramphenicol
2.2.6 Others
2.3 Vancomycin Sales by Type
2.3.1 Global Vancomycin Sales Market Share by Type (2017-2022)
2.3.2 Global Vancomycin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vancomycin Sale Price by Type (2017-2022)
2.4 Vancomycin Segment by Application
2.4.1 Sepsis
2.4.2 Lung Infection
2.4.3 Skin Soft Tissue Infection
2.4.4 Colitis & Intestinal Inflammation
2.4.5 To Prevent Infection
2.5 Vancomycin Sales by Application
2.5.1 Global Vancomycin Sale Market Share by Application (2017-2022)
2.5.2 Global Vancomycin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vancomycin Sale Price by Application (2017-2022)
3 Global Vancomycin by Company
3.1 Global Vancomycin Breakdown Data by Company
3.1.1 Global Vancomycin Annual Sales by Company (2020-2022)
3.1.2 Global Vancomycin Sales Market Share by Company (2020-2022)
3.2 Global Vancomycin Annual Revenue by Company (2020-2022)
3.2.1 Global Vancomycin Revenue by Company (2020-2022)
3.2.2 Global Vancomycin Revenue Market Share by Company (2020-2022)
3.3 Global Vancomycin Sale Price by Company
3.4 Key Manufacturers Vancomycin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vancomycin Product Location Distribution
3.4.2 Players Vancomycin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vancomycin by Geographic Region
4.1 World Historic Vancomycin Market Size by Geographic Region (2017-2022)
4.1.1 Global Vancomycin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vancomycin Annual Revenue by Geographic Region
4.2 World Historic Vancomycin Market Size by Country/Region (2017-2022)
4.2.1 Global Vancomycin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vancomycin Annual Revenue by Country/Region
4.3 Americas Vancomycin Sales Growth
4.4 APAC Vancomycin Sales Growth
4.5 Europe Vancomycin Sales Growth
4.6 Middle East & Africa Vancomycin Sales Growth
5 Americas
5.1 Americas Vancomycin Sales by Country
5.1.1 Americas Vancomycin Sales by Country (2017-2022)
5.1.2 Americas Vancomycin Revenue by Country (2017-2022)
5.2 Americas Vancomycin Sales by Type
5.3 Americas Vancomycin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vancomycin Sales by Region
6.1.1 APAC Vancomycin Sales by Region (2017-2022)
6.1.2 APAC Vancomycin Revenue by Region (2017-2022)
6.2 APAC Vancomycin Sales by Type
6.3 APAC Vancomycin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vancomycin by Country
7.1.1 Europe Vancomycin Sales by Country (2017-2022)
7.1.2 Europe Vancomycin Revenue by Country (2017-2022)
7.2 Europe Vancomycin Sales by Type
7.3 Europe Vancomycin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vancomycin by Country
8.1.1 Middle East & Africa Vancomycin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vancomycin Revenue by Country (2017-2022)
8.2 Middle East & Africa Vancomycin Sales by Type
8.3 Middle East & Africa Vancomycin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vancomycin
10.3 Manufacturing Process Analysis of Vancomycin
10.4 Industry Chain Structure of Vancomycin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vancomycin Distributors
11.3 Vancomycin Customer
12 World Forecast Review for Vancomycin by Geographic Region
12.1 Global Vancomycin Market Size Forecast by Region
12.1.1 Global Vancomycin Forecast by Region (2023-2028)
12.1.2 Global Vancomycin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vancomycin Forecast by Type
12.7 Global Vancomycin Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Vancomycin Product Offered
13.1.3 Pfizer Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Eli Lilly and Company
13.2.1 Eli Lilly and Company Company Information
13.2.2 Eli Lilly and Company Vancomycin Product Offered
13.2.3 Eli Lilly and Company Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly and Company Main Business Overview
13.2.5 Eli Lilly and Company Latest Developments
13.3 CJ CheilJedang
13.3.1 CJ CheilJedang Company Information
13.3.2 CJ CheilJedang Vancomycin Product Offered
13.3.3 CJ CheilJedang Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CJ CheilJedang Main Business Overview
13.3.5 CJ CheilJedang Latest Developments
13.4 Xellia Pharmaceuticals ApS
13.4.1 Xellia Pharmaceuticals ApS Company Information
13.4.2 Xellia Pharmaceuticals ApS Vancomycin Product Offered
13.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Xellia Pharmaceuticals ApS Main Business Overview
13.4.5 Xellia Pharmaceuticals ApS Latest Developments
13.5 VIANEX
13.5.1 VIANEX Company Information
13.5.2 VIANEX Vancomycin Product Offered
13.5.3 VIANEX Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 VIANEX Main Business Overview
13.5.5 VIANEX Latest Developments
13.6 Alchemia Limited
13.6.1 Alchemia Limited Company Information
13.6.2 Alchemia Limited Vancomycin Product Offered
13.6.3 Alchemia Limited Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Alchemia Limited Main Business Overview
13.6.5 Alchemia Limited Latest Developments
13.7 Alvogen
13.7.1 Alvogen Company Information
13.7.2 Alvogen Vancomycin Product Offered
13.7.3 Alvogen Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Alvogen Main Business Overview
13.7.5 Alvogen Latest Developments
13.8 Aphios Corporation
13.8.1 Aphios Corporation Company Information
13.8.2 Aphios Corporation Vancomycin Product Offered
13.8.3 Aphios Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aphios Corporation Main Business Overview
13.8.5 Aphios Corporation Latest Developments
13.9 Cellceutix Corporation
13.9.1 Cellceutix Corporation Company Information
13.9.2 Cellceutix Corporation Vancomycin Product Offered
13.9.3 Cellceutix Corporation Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cellceutix Corporation Main Business Overview
13.9.5 Cellceutix Corporation Latest Developments
13.10 Enanta Pharmaceuticals
13.10.1 Enanta Pharmaceuticals Company Information
13.10.2 Enanta Pharmaceuticals Vancomycin Product Offered
13.10.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Enanta Pharmaceuticals Main Business Overview
13.10.5 Enanta Pharmaceuticals Latest Developments
13.11 Helix BioMedix
13.11.1 Helix BioMedix Company Information
13.11.2 Helix BioMedix Vancomycin Product Offered
13.11.3 Helix BioMedix Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Helix BioMedix Main Business Overview
13.11.5 Helix BioMedix Latest Developments
13.12 LegoChem Biosciences
13.12.1 LegoChem Biosciences Company Information
13.12.2 LegoChem Biosciences Vancomycin Product Offered
13.12.3 LegoChem Biosciences Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 LegoChem Biosciences Main Business Overview
13.12.5 LegoChem Biosciences Latest Developments
13.13 Lytix Biopharma
13.13.1 Lytix Biopharma Company Information
13.13.2 Lytix Biopharma Vancomycin Product Offered
13.13.3 Lytix Biopharma Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lytix Biopharma Main Business Overview
13.13.5 Lytix Biopharma Latest Developments
13.14 MGB Biopharma Limited
13.14.1 MGB Biopharma Limited Company Information
13.14.2 MGB Biopharma Limited Vancomycin Product Offered
13.14.3 MGB Biopharma Limited Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 MGB Biopharma Limited Main Business Overview
13.14.5 MGB Biopharma Limited Latest Developments
13.15 Microbiotix.
13.15.1 Microbiotix. Company Information
13.15.2 Microbiotix. Vancomycin Product Offered
13.15.3 Microbiotix. Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Microbiotix. Main Business Overview
13.15.5 Microbiotix. Latest Developments
13.16 MicuRx Pharmaceuticals
13.16.1 MicuRx Pharmaceuticals Company Information
13.16.2 MicuRx Pharmaceuticals Vancomycin Product Offered
13.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 MicuRx Pharmaceuticals Main Business Overview
13.16.5 MicuRx Pharmaceuticals Latest Developments
13.17 Nabriva Therapeutics
13.17.1 Nabriva Therapeutics Company Information
13.17.2 Nabriva Therapeutics Vancomycin Product Offered
13.17.3 Nabriva Therapeutics Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Nabriva Therapeutics Main Business Overview
13.17.5 Nabriva Therapeutics Latest Developments
13.18 NovaBay Pharmaceuticals
13.18.1 NovaBay Pharmaceuticals Company Information
13.18.2 NovaBay Pharmaceuticals Vancomycin Product Offered
13.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 NovaBay Pharmaceuticals Main Business Overview
13.18.5 NovaBay Pharmaceuticals Latest Developments
13.19 NovoBiotic Pharmaceuticals
13.19.1 NovoBiotic Pharmaceuticals Company Information
13.19.2 NovoBiotic Pharmaceuticals Vancomycin Product Offered
13.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 NovoBiotic Pharmaceuticals Main Business Overview
13.19.5 NovoBiotic Pharmaceuticals Latest Developments
13.20 Oragenics
13.20.1 Oragenics Company Information
13.20.2 Oragenics Vancomycin Product Offered
13.20.3 Oragenics Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Oragenics Main Business Overview
13.20.5 Oragenics Latest Developments
13.21 Sealife Pharma
13.21.1 Sealife Pharma Company Information
13.21.2 Sealife Pharma Vancomycin Product Offered
13.21.3 Sealife Pharma Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Sealife Pharma Main Business Overview
13.21.5 Sealife Pharma Latest Developments
13.22 Taiwan Zhengde Pharmaceutical
13.22.1 Taiwan Zhengde Pharmaceutical Company Information
13.22.2 Taiwan Zhengde Pharmaceutical Vancomycin Product Offered
13.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Taiwan Zhengde Pharmaceutical Main Business Overview
13.22.5 Taiwan Zhengde Pharmaceutical Latest Developments
13.23 Zhejiang Pharmaceutical
13.23.1 Zhejiang Pharmaceutical Company Information
13.23.2 Zhejiang Pharmaceutical Vancomycin Product Offered
13.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Zhejiang Pharmaceutical Main Business Overview
13.23.5 Zhejiang Pharmaceutical Latest Developments
13.24 Zhejiang Haizheng Pharmaceutical
13.24.1 Zhejiang Haizheng Pharmaceutical Company Information
13.24.2 Zhejiang Haizheng Pharmaceutical Vancomycin Product Offered
13.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Zhejiang Haizheng Pharmaceutical Main Business Overview
13.24.5 Zhejiang Haizheng Pharmaceutical Latest Developments
13.25 North China Pharmaceutical
13.25.1 North China Pharmaceutical Company Information
13.25.2 North China Pharmaceutical Vancomycin Product Offered
13.25.3 North China Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 North China Pharmaceutical Main Business Overview
13.25.5 North China Pharmaceutical Latest Developments
13.26 Shenwei Pharmaceutical
13.26.1 Shenwei Pharmaceutical Company Information
13.26.2 Shenwei Pharmaceutical Vancomycin Product Offered
13.26.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Shenwei Pharmaceutical Main Business Overview
13.26.5 Shenwei Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Vancomycin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vancomycin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Daptomycin
Table 4. Major Players of Linezolid
Table 5. Major Players of Quinupristin
Table 6. Major Players of Ampicillin
Table 7. Major Players of Chloramphenicol
Table 8. Major Players of Others
Table 9. Global Vancomycin Sales by Type (2017-2022) & (KG)
Table 10. Global Vancomycin Sales Market Share by Type (2017-2022)
Table 11. Global Vancomycin Revenue by Type (2017-2022) & ($ million)
Table 12. Global Vancomycin Revenue Market Share by Type (2017-2022)
Table 13. Global Vancomycin Sale Price by Type (2017-2022) & (US$/G)
Table 14. Global Vancomycin Sales by Application (2017-2022) & (KG)
Table 15. Global Vancomycin Sales Market Share by Application (2017-2022)
Table 16. Global Vancomycin Revenue by Application (2017-2022)
Table 17. Global Vancomycin Revenue Market Share by Application (2017-2022)
Table 18. Global Vancomycin Sale Price by Application (2017-2022) & (US$/G)
Table 19. Global Vancomycin Sales by Company (2020-2022) & (KG)
Table 20. Global Vancomycin Sales Market Share by Company (2020-2022)
Table 21. Global Vancomycin Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Vancomycin Revenue Market Share by Company (2020-2022)
Table 23. Global Vancomycin Sale Price by Company (2020-2022) & (US$/G)
Table 24. Key Manufacturers Vancomycin Producing Area Distribution and Sales Area
Table 25. Players Vancomycin Products Offered
Table 26. Vancomycin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Vancomycin Sales by Geographic Region (2017-2022) & (KG)
Table 30. Global Vancomycin Sales Market Share Geographic Region (2017-2022)
Table 31. Global Vancomycin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Vancomycin Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Vancomycin Sales by Country/Region (2017-2022) & (KG)
Table 34. Global Vancomycin Sales Market Share by Country/Region (2017-2022)
Table 35. Global Vancomycin Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Vancomycin Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Vancomycin Sales by Country (2017-2022) & (KG)
Table 38. Americas Vancomycin Sales Market Share by Country (2017-2022)
Table 39. Americas Vancomycin Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Vancomycin Revenue Market Share by Country (2017-2022)
Table 41. Americas Vancomycin Sales by Type (2017-2022) & (KG)
Table 42. Americas Vancomycin Sales Market Share by Type (2017-2022)
Table 43. Americas Vancomycin Sales by Application (2017-2022) & (KG)
Table 44. Americas Vancomycin Sales Market Share by Application (2017-2022)
Table 45. APAC Vancomycin Sales by Region (2017-2022) & (KG)
Table 46. APAC Vancomycin Sales Market Share by Region (2017-2022)
Table 47. APAC Vancomycin Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Vancomycin Revenue Market Share by Region (2017-2022)
Table 49. APAC Vancomycin Sales by Type (2017-2022) & (KG)
Table 50. APAC Vancomycin Sales Market Share by Type (2017-2022)
Table 51. APAC Vancomycin Sales by Application (2017-2022) & (KG)
Table 52. APAC Vancomycin Sales Market Share by Application (2017-2022)
Table 53. Europe Vancomycin Sales by Country (2017-2022) & (KG)
Table 54. Europe Vancomycin Sales Market Share by Country (2017-2022)
Table 55. Europe Vancomycin Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Vancomycin Revenue Market Share by Country (2017-2022)
Table 57. Europe Vancomycin Sales by Type (2017-2022) & (KG)
Table 58. Europe Vancomycin Sales Market Share by Type (2017-2022)
Table 59. Europe Vancomycin Sales by Application (2017-2022) & (KG)
Table 60. Europe Vancomycin Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Vancomycin Sales by Country (2017-2022) & (KG)
Table 62. Middle East & Africa Vancomycin Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Vancomycin Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Vancomycin Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Vancomycin Sales by Type (2017-2022) & (KG)
Table 66. Middle East & Africa Vancomycin Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Vancomycin Sales by Application (2017-2022) & (KG)
Table 68. Middle East & Africa Vancomycin Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Vancomycin
Table 70. Key Market Challenges & Risks of Vancomycin
Table 71. Key Industry Trends of Vancomycin
Table 72. Vancomycin Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Vancomycin Distributors List
Table 75. Vancomycin Customer List
Table 76. Global Vancomycin Sales Forecast by Region (2023-2028) & (KG)
Table 77. Global Vancomycin Sales Market Forecast by Region
Table 78. Global Vancomycin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Vancomycin Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Vancomycin Sales Forecast by Country (2023-2028) & (KG)
Table 81. Americas Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Vancomycin Sales Forecast by Region (2023-2028) & (KG)
Table 83. APAC Vancomycin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Vancomycin Sales Forecast by Country (2023-2028) & (KG)
Table 85. Europe Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Vancomycin Sales Forecast by Country (2023-2028) & (KG)
Table 87. Middle East & Africa Vancomycin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Vancomycin Sales Forecast by Type (2023-2028) & (KG)
Table 89. Global Vancomycin Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Vancomycin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Vancomycin Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Vancomycin Sales Forecast by Application (2023-2028) & (KG)
Table 93. Global Vancomycin Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Vancomycin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Vancomycin Revenue Market Share Forecast by Application (2023-2028)
Table 96. Pfizer Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 97. Pfizer Vancomycin Product Offered
Table 98. Pfizer Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 99. Pfizer Main Business
Table 100. Pfizer Latest Developments
Table 101. Eli Lilly and Company Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 102. Eli Lilly and Company Vancomycin Product Offered
Table 103. Eli Lilly and Company Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 104. Eli Lilly and Company Main Business
Table 105. Eli Lilly and Company Latest Developments
Table 106. CJ CheilJedang Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 107. CJ CheilJedang Vancomycin Product Offered
Table 108. CJ CheilJedang Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 109. CJ CheilJedang Main Business
Table 110. CJ CheilJedang Latest Developments
Table 111. Xellia Pharmaceuticals ApS Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 112. Xellia Pharmaceuticals ApS Vancomycin Product Offered
Table 113. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 114. Xellia Pharmaceuticals ApS Main Business
Table 115. Xellia Pharmaceuticals ApS Latest Developments
Table 116. VIANEX Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 117. VIANEX Vancomycin Product Offered
Table 118. VIANEX Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 119. VIANEX Main Business
Table 120. VIANEX Latest Developments
Table 121. Alchemia Limited Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 122. Alchemia Limited Vancomycin Product Offered
Table 123. Alchemia Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 124. Alchemia Limited Main Business
Table 125. Alchemia Limited Latest Developments
Table 126. Alvogen Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 127. Alvogen Vancomycin Product Offered
Table 128. Alvogen Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 129. Alvogen Main Business
Table 130. Alvogen Latest Developments
Table 131. Aphios Corporation Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 132. Aphios Corporation Vancomycin Product Offered
Table 133. Aphios Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 134. Aphios Corporation Main Business
Table 135. Aphios Corporation Latest Developments
Table 136. Cellceutix Corporation Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 137. Cellceutix Corporation Vancomycin Product Offered
Table 138. Cellceutix Corporation Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 139. Cellceutix Corporation Main Business
Table 140. Cellceutix Corporation Latest Developments
Table 141. Enanta Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 142. Enanta Pharmaceuticals Vancomycin Product Offered
Table 143. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 144. Enanta Pharmaceuticals Main Business
Table 145. Enanta Pharmaceuticals Latest Developments
Table 146. Helix BioMedix Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 147. Helix BioMedix Vancomycin Product Offered
Table 148. Helix BioMedix Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 149. Helix BioMedix Main Business
Table 150. Helix BioMedix Latest Developments
Table 151. LegoChem Biosciences Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 152. LegoChem Biosciences Vancomycin Product Offered
Table 153. LegoChem Biosciences Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 154. LegoChem Biosciences Main Business
Table 155. LegoChem Biosciences Latest Developments
Table 156. Lytix Biopharma Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 157. Lytix Biopharma Vancomycin Product Offered
Table 158. Lytix Biopharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 159. Lytix Biopharma Main Business
Table 160. Lytix Biopharma Latest Developments
Table 161. MGB Biopharma Limited Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 162. MGB Biopharma Limited Vancomycin Product Offered
Table 163. MGB Biopharma Limited Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 164. MGB Biopharma Limited Main Business
Table 165. MGB Biopharma Limited Latest Developments
Table 166. Microbiotix. Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 167. Microbiotix. Vancomycin Product Offered
Table 168. Microbiotix. Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 169. Microbiotix. Main Business
Table 170. Microbiotix. Latest Developments
Table 171. MicuRx Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 172. MicuRx Pharmaceuticals Vancomycin Product Offered
Table 173. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 174. MicuRx Pharmaceuticals Main Business
Table 175. MicuRx Pharmaceuticals Latest Developments
Table 176. Nabriva Therapeutics Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 177. Nabriva Therapeutics Vancomycin Product Offered
Table 178. Nabriva Therapeutics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 179. Nabriva Therapeutics Main Business
Table 180. Nabriva Therapeutics Latest Developments
Table 181. NovaBay Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 182. NovaBay Pharmaceuticals Vancomycin Product Offered
Table 183. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 184. NovaBay Pharmaceuticals Main Business
Table 185. NovaBay Pharmaceuticals Latest Developments
Table 186. NovoBiotic Pharmaceuticals Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 187. NovoBiotic Pharmaceuticals Vancomycin Product Offered
Table 188. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 189. NovoBiotic Pharmaceuticals Main Business
Table 190. NovoBiotic Pharmaceuticals Latest Developments
Table 191. Oragenics Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 192. Oragenics Vancomycin Product Offered
Table 193. Oragenics Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 194. Oragenics Main Business
Table 195. Oragenics Latest Developments
Table 196. Sealife Pharma Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 197. Sealife Pharma Vancomycin Product Offered
Table 198. Sealife Pharma Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 199. Sealife Pharma Main Business
Table 200. Sealife Pharma Latest Developments
Table 201. Taiwan Zhengde Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 202. Taiwan Zhengde Pharmaceutical Vancomycin Product Offered
Table 203. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 204. Taiwan Zhengde Pharmaceutical Main Business
Table 205. Taiwan Zhengde Pharmaceutical Latest Developments
Table 206. Zhejiang Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 207. Zhejiang Pharmaceutical Vancomycin Product Offered
Table 208. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 209. Zhejiang Pharmaceutical Main Business
Table 210. Zhejiang Pharmaceutical Latest Developments
Table 211. Zhejiang Haizheng Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 212. Zhejiang Haizheng Pharmaceutical Vancomycin Product Offered
Table 213. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 214. Zhejiang Haizheng Pharmaceutical Main Business
Table 215. Zhejiang Haizheng Pharmaceutical Latest Developments
Table 216. North China Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 217. North China Pharmaceutical Vancomycin Product Offered
Table 218. North China Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 219. North China Pharmaceutical Main Business
Table 220. North China Pharmaceutical Latest Developments
Table 221. Shenwei Pharmaceutical Basic Information, Vancomycin Manufacturing Base, Sales Area and Its Competitors
Table 222. Shenwei Pharmaceutical Vancomycin Product Offered
Table 223. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 224. Shenwei Pharmaceutical Main Business
Table 225. Shenwei Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Vancomycin
Figure 2. Vancomycin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vancomycin Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Vancomycin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vancomycin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Daptomycin
Figure 10. Product Picture of Linezolid
Figure 11. Product Picture of Quinupristin
Figure 12. Product Picture of Ampicillin
Figure 13. Product Picture of Chloramphenicol
Figure 14. Product Picture of Others
Figure 15. Global Vancomycin Sales Market Share by Type in 2021
Figure 16. Global Vancomycin Revenue Market Share by Type (2017-2022)
Figure 17. Vancomycin Consumed in Sepsis
Figure 18. Global Vancomycin Market: Sepsis (2017-2022) & (KG)
Figure 19. Vancomycin Consumed in Lung Infection
Figure 20. Global Vancomycin Market: Lung Infection (2017-2022) & (KG)
Figure 21. Vancomycin Consumed in Skin Soft Tissue Infection
Figure 22. Global Vancomycin Market: Skin Soft Tissue Infection (2017-2022) & (KG)
Figure 23. Vancomycin Consumed in Colitis & Intestinal Inflammation
Figure 24. Global Vancomycin Market: Colitis & Intestinal Inflammation (2017-2022) & (KG)
Figure 25. Vancomycin Consumed in To Prevent Infection
Figure 26. Global Vancomycin Market: To Prevent Infection (2017-2022) & (KG)
Figure 27. Global Vancomycin Sales Market Share by Application (2017-2022)
Figure 28. Global Vancomycin Revenue Market Share by Application in 2021
Figure 29. Vancomycin Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Vancomycin Revenue Market Share by Company in 2021
Figure 31. Global Vancomycin Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Vancomycin Revenue Market Share by Geographic Region in 2021
Figure 33. Global Vancomycin Sales Market Share by Region (2017-2022)
Figure 34. Global Vancomycin Revenue Market Share by Country/Region in 2021
Figure 35. Americas Vancomycin Sales 2017-2022 (KG)
Figure 36. Americas Vancomycin Revenue 2017-2022 ($ Millions)
Figure 37. APAC Vancomycin Sales 2017-2022 (KG)
Figure 38. APAC Vancomycin Revenue 2017-2022 ($ Millions)
Figure 39. Europe Vancomycin Sales 2017-2022 (KG)
Figure 40. Europe Vancomycin Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Vancomycin Sales 2017-2022 (KG)
Figure 42. Middle East & Africa Vancomycin Revenue 2017-2022 ($ Millions)
Figure 43. Americas Vancomycin Sales Market Share by Country in 2021
Figure 44. Americas Vancomycin Revenue Market Share by Country in 2021
Figure 45. United States Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Vancomycin Sales Market Share by Region in 2021
Figure 50. APAC Vancomycin Revenue Market Share by Regions in 2021
Figure 51. China Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Vancomycin Sales Market Share by Country in 2021
Figure 58. Europe Vancomycin Revenue Market Share by Country in 2021
Figure 59. Germany Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Vancomycin Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Vancomycin Revenue Market Share by Country in 2021
Figure 66. Egypt Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Vancomycin Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Vancomycin in 2021
Figure 72. Manufacturing Process Analysis of Vancomycin
Figure 73. Industry Chain Structure of Vancomycin
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...